Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Sales: 2013-2025

Historic Return on Sales for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to 0.06%.

  • Veracyte's Return on Sales rose 8.00% to 0.06% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 8.00%. This contributed to the annual value of 0.05% for FY2024, which is 26.00% up from last year.
  • Veracyte's Return on Sales amounted to 0.06% in Q3 2025, which was up 11.42% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Veracyte's Return on Sales ranged from a high of 0.07% in Q1 2025 and a low of -0.53% during Q1 2021.
  • Its 3-year average for Return on Sales is -0.06%, with a median of -0.09% in 2023.
  • Its Return on Sales has fluctuated over the past 5 years, first slumped by 32bps in 2021, then soared by 34bps in 2022.
  • Over the past 5 years, Veracyte's Return on Sales (Quarterly) stood at -0.34% in 2021, then increased by 22bps to -0.12% in 2022, then declined by 8bps to -0.21% in 2023, then increased by 26bps to 0.05% in 2024, then climbed by 8bps to 0.06% in 2025.
  • Its Return on Sales stands at 0.06% for Q3 2025, versus 0.05% for Q2 2025 and 0.07% for Q1 2025.